MICRO-K EXTENCAPS: POTASSIUM CHLORIDE EXTENDED-RELE.
POTASSIUM CHLORIDE EXTENDED-RELE. Key specifications include special_features: 8 MILLIEQUIVALENT POTASSIUM ION ACTIVE INGREDIENT, long_action_method: EXTENDED RELEASE, primary_container_type: BOTTLE, therapeutic_equivalent: THE A.H. ROBINS CO., medical_designation_and_grade: UNITED STATES PHARMACOPEIA, part_name_assigned_by_controlling_agency: POTASSIUM CHLORIDE EXTENDED RELEASE CAPSULES USP 600MG 500S BT.
This part is cataloged in the U.S. Government catalog under NSN 6505-01-166-2683, indicating validated use in U.S. government and defense logistics supply chains.
Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| special_features | 8 MILLIEQUIVALENT POTASSIUM ION ACTIVE INGREDIENT |
| long_action_method | EXTENDED RELEASE |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | THE A.H. ROBINS CO. |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| part_name_assigned_by_controlling_agency | POTASSIUM CHLORIDE EXTENDED RELEASE CAPSULES USP 600MG 500S BT |
| capsule_primary_container_content_quantity | 500.000 |
| NSN | 6505-01-166-2683 |
| LONG ACTION METHOD | EXTENDED RELEASE |
| THERAPEUTIC EQUIVALENT | THE A.H. ROBINS CO. |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | 8 MILLIEQUIVALENT POTASSIUM ION ACTIVE INGREDIENT |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 500.000 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | POTASSIUM CHLORIDE EXTENDED RELEASE CAPSULES USP 600MG 500S BT |
No substitute or cross-reference records for this part.